Life Insurance Premiums Up by ₹10,000 Crore in April-May Despite Muted Policy Growth

Life insurers increased premiums by ₹10,000 crore from April to May through higher value products and group insurance contracts.
Despite this growth in premiums, policy counts advance only by 5% to 29.6 lakh, as per the news report.
Premium Growth versus Policy Increase
According to the Life Insurance Council, new business premiums increased 19.4% year-on-year to ₹62,581 crore during April-May FY27.
In comparison, the number of policies sold rose by only 5% to 29.6 lakh. This disparity indicates a shift in industry focus towards high-premium contracts.
Growth in life insurance is increasingly driven by more significant ticket sizes as opposed to simply expanding the customer base.
Dominance of Group Single-Premium Business
The group single-premium segment led this premium increase, growing by over 20% to ₹37,537 crore. It accounted for nearly 60% of the industry premiums during the period.
Individual non-single premium policies, which indicate long-term retail insurance penetration, saw premiums rise by 16.7% but policy growth was just 4.8%.
Read More: SBI General Insurance IPO to Follow AMC’s Listing, Says Chairman CS Setty!
Private versus Public Sector Performance
Premium expansion outpaced customer acquisition across the board. Private life insurers experienced a 21.3% rise in premium income and a 13.7% increase in policies.
LIC reported an 18.1% increase in premiums, with a negligible 0.1% policy growth, reflecting the concentration of growth among existing customers and institutional contracts.
Conclusion
Life insurers added ₹10,000 crore in premiums during April-May FY27, driven by significant group single-premium business at ₹37,537 crore. Despite a 19.4% increase in premiums, policy growth was limited to 5%.
Want to track these market movements in Hindi? Visit Angel One News for daily updates and comprehensive share market news in Hindi.
Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Jun 11, 2026, 11:05 AM IST

Team Angel One
- Top Gainers and Losers on September 7, 2026: Apollo Hospitals and L&T Rise, While Infosys Drops Over 3%
- JLR Plans Job Cuts as UK Government Rules Out Financial Support
- Novartis India Share Price in Focus; Approves ₹1,250 Crore Acquisition of Minipress & Minipres Trademarks
- Auto Retail Sales Rise 18% in August 2026 to Record 2.42 Million Units, Says FADA
- Nifty Smallcap 100 Index Flat in Intraday Trade on September 7, 2026


